Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4877 in Japanese Patients with Solid Tumors

por Esaki, Taito, Seto, Takashi, Ariyama, Hiroshi, Arita, Shuji, Fujimoto, Chinatsu, Tsukasa, Koichiro, Kometani, Takuro, Nosaki, Kaname, Hirai, Fumihiko, Yagawa, Katsuro
Publicado 2011

A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report

por Yamaguchi, Masafumi, Hirai, Fumihiko, Taguchi, Kenichi, Toyozawa, Ryo, Edagawa, Makoto, Shimamatsu, Shinichiro, Nosaki, Kaname, Seto, Takashi, Takenoyama, Mitsuhiro, Ichinose, Yukito
Publicado 2017

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients

por Katsura, Masakazu, Shoji, Fumihiro, Okamoto, Tatsuro, Shimamatsu, Shinichiro, Hirai, Fumihiko, Toyokawa, Gouji, Morodomi, Yosuke, Tagawa, Tetsuzo, Oda, Yoshinao, Maehara, Yoshihiko
Publicado 2017

Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report

por Takamori, Shinkichi, Yamaguchi, Masafumi, Taguchi, Kenichi, Edagawa, Makoto, Shimamatsu, Shinichiro, Toyozawa, Ryo, Nosaki, Kaname, Hirai, Fumihiko, Seto, Takashi, Takenoyama, Mitsuhiro, Ichinose, Yukito
Publicado 2017

The clinical impact of concomitant medication use on the outcome of postoperative recurrent non-small-cell lung cancer in patients receiving immune checkpoint inhibitors

por Takada, Kazuki, Shimokawa, Mototsugu, Takamori, Shinkichi, Shimamatsu, Shinichiro, Hirai, Fumihiko, Ono, Yuki, Tagawa, Tetsuzo, Okamoto, Tatsuro, Hamatake, Motoharu, Okamoto, Isamu, Mori, Masaki
Publicado 2022

Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non–Small-Cell Lung Cancer or Other Tumors

por Nishio, Makoto, Murakami, Haruyasu, Horiike, Atsushi, Takahashi, Toshiaki, Hirai, Fumihiko, Suenaga, Naoko, Tajima, Takeshi, Tokushige, Kota, Ishii, Masami, Boral, Anthony, Robson, Matthew, Seto, Takashi
Publicado 2015

Phase 1 study of pembrolizumab (MK-3475; anti-PD-1 monoclonal antibody) in Japanese patients with advanced solid tumors

por Shimizu, Toshio, Seto, Takashi, Hirai, Fumihiko, Takenoyama, Mitsuhiro, Nosaki, Kaname, Tsurutani, Junji, Kaneda, Hiroyasu, Iwasa, Tsutomu, Kawakami, Hisato, Noguchi, Kazuo, Shimamoto, Takashi, Nakagawa, Kazuhiko
Publicado 2016

Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours

por Yonemori, Kan, Tamura, Kenji, Kodaira, Makoto, Fujikawa, Koshi, Sagawa, Tamotsu, Esaki, Taito, Shirakawa, Tsuyoshi, Hirai, Fumihiko, Yokoi, Yuki, Kawata, Toshio, Hatano, Ben, Takahashi, Yasuo
Publicado 2016

Phase I dose‐escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors

por Esaki, Taito, Hirai, Fumihiko, Makiyama, Akitaka, Seto, Takashi, Bando, Hideaki, Naito, Yoichi, Yoh, Kiyotaka, Ishihara, Kae, Kakizume, Tomoyuki, Natsume, Kazuto, Myers, Andrea, Doi, Toshihiko
Publicado 2019

Recurrence of thymic neuroendocrine carcinoma 24 years after total excision: A case report

por TOYOKAWA, GOUJI, TAGUCHI, KENICHI, KOJO, MIYAKO, TOYOZAWA, RYO, INAMASU, EIKO, MORODOMI, YOSUKE, SHIRAISHI, YOSHIMASA, TAKENAKA, TOMOYOSHI, HIRAI, FUMIHIKO, YAMAGUCHI, MASAFUMI, SETO, TAKASHI, TAKENOYAMA, MITSUHIRO, ICHINOSE, YUKITO
Publicado 2013

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors

por Tamura, Kenji, Hashimoto, Jun, Tanabe, Yuko, Kodaira, Makoto, Yonemori, Kan, Seto, Takashi, Hirai, Fumihiko, Arita, Shuji, Toyokawa, Gouji, Chen, Lan, Yamamoto, Hiroshi, Kawata, Toshio, Lindemann, Justin, Esaki, Taito
Publicado 2016

Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9

por Hida, Toyoaki, Seto, Takashi, Horinouchi, Hidehito, Maemondo, Makoto, Takeda, Masayuki, Hotta, Katsuyuki, Hirai, Fumihiko, Kim, Young Hak, Matsumoto, Shingo, Ito, Masayuki, Ayukawa, Koichi, Tokushige, Kota, Yonemura, Masataka, Mitsudomi, Testuya, Nishio, Makoto
Publicado 2018

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retro...

por Takada, Kazuki, Shimokawa, Mototsugu, Takamori, Shinkichi, Shimamatsu, Shinichiro, Hirai, Fumihiko, Tagawa, Tetsuzo, Okamoto, Tatsuro, Hamatake, Motoharu, Tsuchiya-Kawano, Yuko, Otsubo, Kohei, Inoue, Koji, Yoneshima, Yasuto, Tanaka, Kentaro, Okamoto, Isamu, Nakanishi, Yoichi, Mori, Masaki
Publicado 2022

The significant influence of having children on the postoperative prognosis of patients with nonsmall cell lung cancer: A propensity score‐matched analysis

por Takamori, Shinkichi, Tagawa, Tetsuzo, Toyokawa, Gouji, Ueo, Hiroki, Shimokawa, Mototsugu, Kinoshita, Fumihiko, Matsubara, Taichi, Kozuma, Yuka, Haratake, Naoki, Akamine, Takaki, Katsura, Masakazu, Takada, Kazuki, Hirai, Fumihiko, Shoji, Fumihiro, Okamoto, Tatsuro, Oda, Yoshinao, Maehara, Yoshihiko
Publicado 2018

Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non‐small‐cell lung cancer

por Otsubo, Kohei, Nosaki, Kaname, Imamura, Chiyo K., Ogata, Hiroaki, Fujita, Akitaka, Sakata, Shinya, Hirai, Fumihiko, Toyokawa, Gouji, Iwama, Eiji, Harada, Taishi, Seto, Takashi, Takenoyama, Mitsuhiro, Ozeki, Takeshi, Mushiroda, Taisei, Inada, Mieko, Kishimoto, Junji, Tsuchihashi, Kenji, Suina, Kentaro, Nagano, Osamu, Saya, Hideyuki, Nakanishi, Yoichi, Okamoto, Isamu
Publicado 2017